Abstract
Purpose
To introduce the clinical utility of multifocal visual evoked potential (mfVEP) and to assess the waveform from normal Korean subjects.
Methods
mfVEP with 4 channel recording was performed using the RETIscan® system (Roland Consult, Wiesbaden, Germany) for 25 eyes of 25 normal subjects. Amplitudes and implicit times were obtained from ring-shaped 6 areas and 4 sectors. To investigate the false-positive ratio of the examination, stimuli were given with one-half of the CRT monitor completely covered and the results were compared.
References
2. Odom JV, Bach M, Barber C, et al. Visual evoked potentials abdominal (2004). Doc Ophthalmol. 2004; 108:115–23.
3. Oh YD, Kwak HW, Kim SM. Evaluation of clinically applied VEP (visual evoked potential) in ophthalmological and abdominal diseases. J Korean Ophthalmol Soc. 1985; 26:1041–5.
4. Halliday AM, McDonald WI, Mushin J. Delayed visual evoked abdominal in optic neuritis. Lancet. 1972; 1:982–5.
5. Halliday AM, McDonald WI, Mushin J. Visual evoked response in diagnosis of multiple sclerosis. Br Med J. 1973; 4:661–4.
6. Halliday AM, Michael WF. Changes in pattern-evoked responses in man associated with the vertical and horizontal meridians of the visual field. J Physiol. 1970; 208:499–513.
7. Harding GF, Odom JV, Spileers W, et al. Standard for visual evoked potentials 1995. International Society for Clinical Electrophysiology of Vision. Vision Res. 1996; 36:3567–72.
8. Fortune B, Hood DC. Comparison of conventional and abdominal VEPs. Invest Ophthalmol Vis Sci. 2003; 44:1364–75.
9. Winn BJ, Shin E, Odel JG, et al. Interpreting the multifocal visual evoked potential: the effects of refractive errors, cataracts, and abdominal errors. Br J Ophthalmol. 2005; 89:340–4.
10. Klistorner AI, Graham SL. Objective perimetry in glaucoma. Ophthalmology. 2000; 107:2283–99.
11. Hood DC, Zhang X, Greenstein VE, et al. An interocular abdominal of the multifocal VEP: a possible technique for detecting local damage to the optic nerve. Invest Ophthalmol Vis Sci. 2000; 41:1580–7.
12. Fortune B, Zhang X, Hood DC, et al. Normative ranges and abdominal of the multifocal VEP. Doc Ophthalmol. 2004; 109:87–100.
13. Sutter EE. Imaging visual function with the multifocal m-se-quence technique. Vision Res. 2001; 41:1241–55.
14. Baseler HA, Sutter EE, Klein SA, Carney T. The topography of visual evoked response properties across the visual field. Electroencephlogr Clin Neurophysiol. 1994; 90:65–81.
15. Graham SL, Klistorner AI, Grigg JR, et al. Obejective VEP abdominal in glaucoma: asymmetry analysis to identity early deficits. J Glaucoma. 2000; 9:10–9.
16. Hood DC, Odel JG, Zhang X. Tracking the recovery of local abdominal nerve function after optic neuritis: a multifocal VEP study. Invest Ophthalmol Vis Sci. 2000; 41:4032–8.
17. Hood DC, Greenstein VC, Odel JG, et al. Visual field defects and multifocal visual evoked potentials. Arch Ophthalmol. 2002; 120:1672–81.
18. Hood DC. Assessing retinal function with the multifocal technique. Prog Retin Eye Res. 2000; 19:607–46.
19. Hood DC, Odel JG, Winn BJ. The multifocal visual evoked potential. J Neuroophthalmol. 2003; 23:279–89.
20. Fortune B, Hood DC, Johnson CA. Comparison of conventional and multifocal VEPs. Invest Ophthalmol Vis Sci. 2003; 44:1364–75.
21. Zhang X, Hood DC. A principle component analysis of abdominal pattern reversal VEP. J Vis. 2004; 4:32–43.
22. Hood DC, Zhang X, Hong JE, Chen CS. Quantifying the benefits of additional channels of multifocal VEP recording. Doc Ophthalmol. 2002; 104:303–20.
23. Daniel PM, Whitterridge W. The representation of the visual field on the cerebral cortex in monkeys. J Physiol. 1961; 159:203–21.
24. Horton JC, Hoyt WF. The representation of the visual field in abdominal striate cortex: revision of the classic Holmes map. Arch Ophthalmol. 1991; 109:816–24.
Table 1.
Area 1 | Area 2 | Area 3 | Area 4 | Area 5 | Area 6 | p-value* | |
---|---|---|---|---|---|---|---|
P1 amplitude | 0.400±0.362 | 0.347±0.304 | 0.171±0.194 | 0.170±0.196 | 0.127±0.140 | 0.094±0.103 | <0.001 |
N2 amplitude | 0.565±0.614 | 0.471±0.519 | 0.242±0.322 | 0.233±0.253 | 0.150±0.178 | 0.141±0.159 | <0.001 |
P1 implicit time | 93.88±11.98 | 94.64±13.37 | 93.74±14.96 | 92.56±16.14 | 93.92±15.50 | 92.94±17.91 | 0.217 |
N2 implicit time | 120.21±17.49 | 123.77±19.43 | 120.22±23.51 | 124.56±23.19 | 124.45±24.08 | 120.47±23.49 | 0.101 |
Table 2.
Inferotemporal | Superotemporal | Superonasal | Inferonasal | p-value* | |
---|---|---|---|---|---|
P1 amplitude | 0.200±0.215 | 0.169±0.193 | 0.160±0.207 | 0.226±0.241 | <0.001 |
N2 amplitude | 0.267±0.388 | 0.212±0.273 | 0.279±0.273 | 0.271±0.262 | 0.057 |
P1 implicit time | 92.84±15.44 | 93.19±16.08 | 92.82±15.46 | 94.32±15.40 | 0.554 |
N2 implicit time | 123.31±24.51 | 123.59±21.87 | 123.38±23.27 | 125.48±21.90 | 0.556 |